The global market for asthma and chronic obstructive pulmonary disease (COPD) drugs is estimated to have a significant CAGR during the forecast period. The market is mainly driven due to increasing prevalence of respiratory diseases such as asthma and COPD across the globe coupled with growing R&D for the development of new drugs. Asthma is one of the major respiratory diseases that has affected almost every major economy across the globe. During an asthma attack, the lining of the bronchial tubes swells, which results in narrowing of airways and reduced flow of air through lungs. According to the Global Asthma Report 2018, Asthma affects 339 million people across all regions. It is one of the major causes of death and disability as nearly 1,000 people lost their lives each day due to asthma. Moreover, it was estimated that 3.17 million mortalities were caused due to COPD in 2015, which is 5% of all the mortalities across the globe in 2016.Therefore significant number of asthma and COPD contribute in the market.
To Request a Sample of our Report on Global Asthma and COPD Drugs Market: https://www.omrglobal.com/request-sample/asthma-and-copd-drugs-market
The global asthma and COPD drugs market is segmented based on disease type and application. Based on the disease type, the market is further classified into asthma and COPD. The asthma segment is projected to have considerable share owing to the high demand of drug treatment in asthma coupled with growing asthma across the globe. Based on the drug class, the global asthma and COPD drugs market is further segmented into anti-inflammatory drugs, combination drugs, monoclonal antibodies, bronchodilators.
(Get 15% Discount on Buying this Report)
A full Report of Global Asthma and COPD Drugs Market is Available at: https://www.omrglobal.com/industry-reports/asthma-and-copd-drugs-market
Global Asthma and COPD Drugs Market Segmentation
By Disease Type
- Asthma
- COPD
By Drug class
- Anti-inflammatory Drugs
- Combination Drugs
- Monoclonal Antibodies
- Bronchodilators
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of The World
Company Profiles
- Amgen Inc.
- AptarGroup, Inc.
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Cipla Ltd.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Grifols, S.A.
- Glenmark Pharmaceuticals
- Merck & Co., Inc.
- MediciNova, Inc.
- Mylan N.V.
- Novartis AG
- Pfizer Inc.
- Respiratorius AB
- Teva Pharmaceutical Industries Ltd.
- Vectura Group plc
- Verona Pharma plc
Reasons to Buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asthma-and-copd-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
